PUBLISHER: The Business Research Company | PRODUCT CODE: 1702773
PUBLISHER: The Business Research Company | PRODUCT CODE: 1702773
Arachidonic acid, an essential polyunsaturated omega-6 fatty acid, plays crucial roles in physiological functions such as maintaining cell membrane integrity and fluidity. It serves as a precursor to eicosanoids such as prostaglandins, thromboxanes, and leukotrienes, which are key players in cellular signaling and immune responses.
There are two primary forms of arachidonic acid, solid and solvent. Solid arachidonic acid denotes the crystalline or powdered form used across various sectors. Its sources range from animals to plants, and its applications include food, pharmaceuticals, cosmetics, and animal feed. These applications cater to both human consumption and industrial needs.
The arachidonic acid research report is one of a series of new reports from The Business Research Company that provides arachidonic acid market statistics, including the arachidonic acid industry's global market size, regional shares, competitors with an arachidonic acid market share, detailed arachidonic acid market segments, market trends and opportunities, and any further data you may need to thrive in the arachidonic acid industry. This arachidonic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The arachidonic acid market size has grown strongly in recent years. It will grow from $5.88 billion in 2024 to $6.4 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to high awareness of the health benefits, rise in birth rates and the increasing number of working mothers, positive regulatory approvals and safety endorsements, increased public and scientific understanding, and rapid urbanization.
The arachidonic acid market size is expected to see strong growth in the next few years. It will grow to $8.87 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to the rising incidence of lifestyle-related disorders, increasing demand for sports supplements, growing regulatory acceptance for oil-based ara products, increasing demand from the pharmaceutical industry, and increasing geriatric population. Major trends in the forecast period include rapid technological developments, innovative solvent-based product portfolios, technological advancements in production, partnerships and collaborations, and endorsements and recommendations.
The arachidonic acid market is poised for growth due to the increasing popularity of functional foods. These foods, known for their health benefits beyond basic nutrition, are gaining traction among consumers seeking to prevent disease and improve well-being. Arachidonic acid plays a crucial role in functional foods, especially in promoting healthy brain development and regulating inflammatory responses, commonly found in infant formulas and nutritional supplements. Notably, in March 2023, Agriculture and Agri-Food Canada (AAFC) reported that fortified or functional (FF) packaged food products, accounting for 40.3% of the health and wellness (HW) foods and beverages market, achieved the highest sales value at US$11.7 billion. This trend underscores the significant impact of functional foods on driving the arachidonic acid market's growth.
The increasing spending on sports nutrition is expected to drive the growth of the arachidonic acid market. Sports nutrition, which focuses on the role of diet and nutrition in athletic performance and physical activity, has seen significant growth as consumers become more aware of its impact on health and performance. Arachidonic acid, an omega-6 fatty acid, plays a crucial role in sports nutrition by supporting muscle growth, improving performance, and aiding recovery through its effects on inflammation and muscle protein synthesis. For example, in September 2024, Nutrabay, an India-based sports nutrition company, raised $5 million in Series A funding to expand its reach across retail platforms and enhance its product offerings. This growing investment in sports nutrition is expected to contribute to increased demand for ingredients like arachidonic acid, thus propelling the market forward.
In August 2023, Bioz Inc., a US-based provider of software solutions, collaborated with Avanti Polar Lipids to enhance the research process for scientists. This partnership leverages Bioz's AI-powered search engine to deliver peer-reviewed data and product validation tools for Avanti's lipid products, including arachidonic acid. By providing scientists with reliable information and aiding in informed purchasing decisions, this collaboration aims to accelerate research discoveries in the field of lipid products and their applications.
Major companies operating in the arachidonic acid market are Cargill Inc., BASF SE, Thermo Fisher Scientific Inc., Merck KGaA, Koninklijke DSM N.V., PerkinElmer Inc., Bio-Techne Corporation, Kingdomway Nutrition Inc., Sisco Research Laboratories Pvt. Ltd., Tokyo Chemical Industry Co. Ltd., Cayman Chemical Company, Parchem Fine and Specialty Chemicals Inc., Avanti Polar Lipids Inc., Acros Organics, Selleck Chemicals LLC, Enzo Life Sciences, Polychemtech India, Spectrum Labs Inc., Cabio Biotech (Wuhan) Co. Ltd., Wuhan Fuxing Biotechnology Co. Ltd.
North America was the largest region in the arachidonic acid market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the arachidonic acid market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the arachidonic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The arachidonic acid market consists of sales of products including prostaglandins, leukotrienes, hydroxyeicosatetraenoic acids, and eicosatrienoic acids. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Arachidonic Acid Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on arachidonic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for arachidonic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The arachidonic acid market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.